We suspect that this reflects the high frequency of immunosuppressive monocytic cells such as myeloid-derived suppressor cells within GBM patients’ CD14+ monocytes.16,17 Through empiric modification, we were able to develop a culture method that results in high levels of CD83+ mature DCs (technique M7). The gene discussed is CD14; the disease is glioblastoma.